BR112012023046A2 - vacinas de vírus de febre aftosa recombinantes e seus respectivos usos - Google Patents
vacinas de vírus de febre aftosa recombinantes e seus respectivos usosInfo
- Publication number
- BR112012023046A2 BR112012023046A2 BR112012023046A BR112012023046A BR112012023046A2 BR 112012023046 A2 BR112012023046 A2 BR 112012023046A2 BR 112012023046 A BR112012023046 A BR 112012023046A BR 112012023046 A BR112012023046 A BR 112012023046A BR 112012023046 A2 BR112012023046 A2 BR 112012023046A2
- Authority
- BR
- Brazil
- Prior art keywords
- fmdv
- virus vaccines
- mouth virus
- recombinant foot
- recombinant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31316410P | 2010-03-12 | 2010-03-12 | |
US36636310P | 2010-07-21 | 2010-07-21 | |
PCT/US2011/028115 WO2011112945A2 (en) | 2010-03-12 | 2011-03-11 | Foot and mouth disease virus recombinant vaccines and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112012023046A2 true BR112012023046A2 (pt) | 2017-07-18 |
BR112012023046B1 BR112012023046B1 (pt) | 2020-04-07 |
Family
ID=43923659
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012023852-3A BR112012023852B1 (pt) | 2010-03-12 | 2011-03-11 | vacinas recombinantes do vírus da língua azul e usos das mesmas |
BR112012023046A BR112012023046B1 (pt) | 2010-03-12 | 2011-03-11 | vacinas de vírus de febre aftosa recombinantes e seus respectivos usos |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012023852-3A BR112012023852B1 (pt) | 2010-03-12 | 2011-03-11 | vacinas recombinantes do vírus da língua azul e usos das mesmas |
Country Status (15)
Country | Link |
---|---|
US (3) | US9345759B2 (pt) |
EP (4) | EP3093025B1 (pt) |
JP (1) | JP2013522300A (pt) |
CN (2) | CN103687614B (pt) |
AR (1) | AR080515A1 (pt) |
AU (1) | AU2011224188B2 (pt) |
BR (2) | BR112012023852B1 (pt) |
CA (2) | CA2792117C (pt) |
ES (2) | ES2795148T3 (pt) |
IL (3) | IL221781B (pt) |
MA (1) | MA34087B1 (pt) |
NZ (2) | NZ702145A (pt) |
RU (1) | RU2575599C2 (pt) |
WO (2) | WO2011112945A2 (pt) |
ZA (1) | ZA201206619B (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0809435A2 (pt) | 2007-03-27 | 2014-09-09 | Sea Lane Biotechnologies Llc | Constructos e bibliotecas que compreendem sequências de cadeia leve substituida de anticorpos |
CN102482345A (zh) | 2009-05-13 | 2012-05-30 | 航道生物技术有限责任公司 | 针对流感病毒的中和分子 |
CN106987595B (zh) | 2009-11-02 | 2021-07-06 | 宾夕法尼亚大学托管会 | 口蹄疫病毒病毒(fmdv)共有蛋白质、其编码序列及由其制备的疫苗 |
CA2842860A1 (en) | 2011-07-28 | 2013-01-31 | Sea Lane Biotechnologies, Llc | Sur-binding proteins |
WO2013096828A1 (en) | 2011-12-22 | 2013-06-27 | Sea Lane Biotechnologies, Llc | Surrogate binding proteins |
MY196679A (en) | 2012-09-05 | 2023-04-29 | Medicago Inc | Picornavirus-Like Particle Production In Plants |
US20140090108A1 (en) * | 2012-09-18 | 2014-03-27 | Freydoun Garabagi | Vectors and Methods For Enhancing Recombinant Protein Expression in Plants |
MX2015011487A (es) * | 2013-03-15 | 2016-02-03 | Univ Pennsylvania | Proteinas de consenso para el virus de la enfermedad de la fiebre aftosa (fmdv), secuencias de codificacion para estas y vacunas elaboradas a partir de estas. |
NZ712410A (en) * | 2013-03-26 | 2020-01-31 | The Pirbright Inst | Stabilised fmdv capsids |
US10872313B2 (en) | 2015-06-02 | 2020-12-22 | ROCA Medical Ltd. | Method for repurposing NDC codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy |
US10010605B2 (en) * | 2014-09-23 | 2018-07-03 | Merial, Inc. | FMDV recombinant vaccines and uses thereof |
CN111925423B (zh) * | 2014-11-07 | 2022-08-19 | 普莱柯生物工程股份有限公司 | 一种抗o型口蹄疫的疫苗组合物及其制备方法和应用 |
US10369215B2 (en) | 2015-06-02 | 2019-08-06 | ROCA Medical Ltd. | Predilution sets for distributing antigens |
US10548974B2 (en) * | 2015-06-02 | 2020-02-04 | ROCA Medical Ltd. | Therapeutic treatment kit for allergies based on DNA profiles |
CN107709554A (zh) * | 2015-06-15 | 2018-02-16 | 巴法里安诺迪克有限公司 | 重组经修饰痘苗病毒安卡拉(mva)口蹄疫病毒(fmdv)疫苗 |
KR102153303B1 (ko) | 2015-11-23 | 2020-09-09 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | Fmdv 및 e2 융합 단백질 및 이의 용도 |
WO2017097875A1 (en) * | 2015-12-08 | 2017-06-15 | Danmarks Tekniske Universitet | Kit-of-parts for use in a prime-boost vaccination strategy to protect cloven-footed animals against foot-and-mouth disease virus infection |
TWI730037B (zh) * | 2016-01-26 | 2021-06-11 | 日商富士軟片和光純藥股份有限公司 | 光硬化方法,及用於該光硬化方法之化合物和組成物 |
TWI760322B (zh) * | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
WO2017182958A1 (en) * | 2016-04-19 | 2017-10-26 | Csir | Plant-produced chimaeric orbivirus vlps |
US10385319B2 (en) | 2016-09-08 | 2019-08-20 | The Governement of the United States of America, as represented by the Secretary of Homeland Security | Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof |
US10435695B2 (en) | 2016-09-08 | 2019-10-08 | The Government of the United States of America, as represented by the Secretary of Homeland Security | Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences |
WO2019023920A1 (zh) * | 2017-08-01 | 2019-02-07 | 金普诺安生物科技(苏州)有限公司 | 一种口蹄疫病毒样颗粒疫苗及其制备方法 |
KR102165358B1 (ko) * | 2017-12-29 | 2020-10-14 | (주)플럼라인생명과학 | 구제역 바이러스 a형 백신 조성물 |
CN108273054B (zh) * | 2018-01-25 | 2020-11-17 | 中国农业科学院兰州兽医研究所 | 猪口蹄疫病毒O型、A型Fc多肽双价疫苗及其制备方法和应用 |
CN111233984B (zh) * | 2018-11-29 | 2022-08-12 | 普莱柯生物工程股份有限公司 | 一种o型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用 |
MX2022014756A (es) | 2020-05-27 | 2023-05-16 | Us Agriculture | Cepas vivas atenuadas de fiebre aftosa modificadas por desoptimizacion y usos de las mismas. |
CN117801099B (zh) * | 2023-12-11 | 2024-08-30 | 中国农业科学院兰州兽医研究所 | 一株抗蓝舌病毒vp7蛋白的重组单克隆抗体 |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
US5110587A (en) | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
JPS60500673A (ja) | 1983-03-08 | 1985-05-09 | コモンウエルス セラム ラボラトリ−ズ コミツシヨン | 抗原活性を有するアミノ酸配列 |
US5380831A (en) | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
US4761373A (en) | 1984-03-06 | 1988-08-02 | Molecular Genetics, Inc. | Herbicide resistance in plants |
DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
JPH0795952B2 (ja) | 1986-01-08 | 1995-10-18 | カルジ−ン・インコ−ポレイテツド | ハロアリ−ルニトリル分解遺伝子、その使用および該遺伝子含有細胞 |
EP0260148A3 (en) | 1986-09-12 | 1989-06-07 | Genentech, Inc. | Improved recombinant expression method, vector and transformed cells |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
CA1341245C (en) | 1988-01-12 | 2001-06-05 | F. Hoffmann-La Roche Ag | Recombinant vaccinia virus mva |
US5990387A (en) | 1988-06-10 | 1999-11-23 | Pioneer Hi-Bred International, Inc. | Stable transformation of plant cells |
NZ230375A (en) | 1988-09-09 | 1991-07-26 | Lubrizol Genetics Inc | Synthetic gene encoding b. thuringiensis insecticidal protein |
CA2024811A1 (en) | 1989-02-24 | 1990-08-25 | David A. Fischhoff | Synthetic plant genes and method for preparation |
US5879918A (en) | 1989-05-12 | 1999-03-09 | Pioneer Hi-Bred International, Inc. | Pretreatment of microprojectiles prior to using in a particle gun |
US5690938A (en) * | 1989-07-07 | 1997-11-25 | Oravax, Inc. | Oral immunization with multiple particulate antigen delivery system |
GB8915572D0 (en) * | 1989-07-07 | 1989-08-23 | Natural Environment Res | Use of bluetongue virus proteins as vaccine components |
EP0528819A1 (en) | 1990-04-18 | 1993-03-03 | Plant Genetic Systems, N.V. | Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells |
US5932782A (en) | 1990-11-14 | 1999-08-03 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species adhered to microprojectiles |
AU672359B2 (en) | 1991-03-07 | 1996-10-03 | Virogenetics Corporation | Genetically engineered vaccine strain |
TW261517B (pt) | 1991-11-29 | 1995-11-01 | Mitsubishi Shozi Kk | |
JP2952041B2 (ja) | 1992-07-27 | 1999-09-20 | パイオニア ハイ−ブレッド インターナショナル,インコーポレイテッド | 培養ダイズ細胞のagrobacterium媒介形質転換の改良法 |
CN1061376C (zh) | 1993-11-19 | 2001-01-31 | 生物技术研究及发展有限公司 | 用于植物体内基因表达的嵌合调节区和基因盒 |
EP0826063A1 (en) | 1995-04-25 | 1998-03-04 | Vical Incorporated | Single-vial formulations of dna/lipid complexes |
US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
DE69733020T2 (de) | 1996-10-11 | 2006-02-16 | The Regents Of The University Of California, Oakland | Immunostimulierende oligonucleotidekonjugate |
US6045774A (en) | 1997-01-10 | 2000-04-04 | Epicyte Pharmaceutical Inc. | J chain polypeptide targeting molecule linked to an imaging agent |
US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
IL133710A0 (en) | 1997-06-30 | 2001-04-30 | Rhone Poulence Rorer S A | Improved method for transferring nucleic acid into the striped muscle and combination thereof |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
US7161064B2 (en) | 1997-08-12 | 2007-01-09 | North Carolina State University | Method for producing stably transformed duckweed using microprojectile bombardment |
FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
US8003772B2 (en) | 1999-01-14 | 2011-08-23 | Martek Biosciences Corporation | Chimeric PUFA polyketide synthase systems and uses thereof |
FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
FR2810888B1 (fr) * | 2000-06-29 | 2004-07-30 | Merial Sas | Vaccin contre la fievre aphteuse |
US7632983B2 (en) | 2000-07-31 | 2009-12-15 | Biolex Therapeutics, Inc. | Expression of monoclonal antibodies in duckweed |
DK1305437T3 (da) | 2000-07-31 | 2010-12-13 | Biolex Therapeutics Inc | Ekspression af biologisk aktive polypeptider i andemad |
US8022270B2 (en) * | 2000-07-31 | 2011-09-20 | Biolex Therapeutics, Inc. | Expression of biologically active polypeptides in duckweed |
AU2001288958A1 (en) | 2000-09-06 | 2002-03-22 | Darrel Roland Anthis | Auxiliary pipe loading device |
TWI324181B (en) | 2001-04-16 | 2010-05-01 | Martek Biosciences Corp | Product and process for transformation of thraustochytriales microorganisms |
EP1397676B1 (en) | 2001-05-30 | 2009-12-30 | Biolex Therapeutics, Inc. | Use of duckweed in high throughput screening |
RU2207877C1 (ru) * | 2001-11-09 | 2003-07-10 | Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко | Вакцина для профилактики и лечения трихофитии крупного, мелкого рогатого скота и оленей |
US6680200B2 (en) | 2002-02-22 | 2004-01-20 | Biolex, Inc. | Led array for illuminating cell well plates and automated rack system for handling the same |
CA2478294C (en) * | 2002-03-19 | 2013-09-03 | Plant Research International B.V. | Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
US7176024B2 (en) | 2003-05-30 | 2007-02-13 | Biolex, Inc. | Bioreactor for growing biological materials supported on a liquid surface |
AU2004259034C1 (en) | 2003-07-24 | 2010-12-16 | Boehringer Ingelheim Animal Health USA Inc. | Vaccine formulations comprising an oil-in-water emulsion |
EP1773387B1 (en) * | 2004-06-25 | 2013-06-12 | Merial Ltd. | Avipox recombinants expressing foot and mouth disease virus genes |
CN100582122C (zh) * | 2006-05-12 | 2010-01-20 | 北京宝麦德生物医药科技有限责任公司 | O型口蹄疫病毒多表位粘膜免疫疫苗及其应用 |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
CN101082051A (zh) * | 2006-06-02 | 2007-12-05 | 广东出入境检验检疫局检验检疫技术中心 | 重组口蹄疫病毒多肽片段及其应用 |
CN101121938B (zh) * | 2007-03-23 | 2010-10-06 | 中国农业科学院兰州兽医研究所 | 一种口蹄疫抗原的制备方法 |
KR101749130B1 (ko) * | 2007-11-26 | 2017-06-20 | 런던 스쿨 오브 하이진 앤 트로피컬 메디신 | 레오바이러스과 바이러스의 백신용 바이러스 균주를 제조하는 방법 |
PT2610345E (pt) | 2007-11-27 | 2016-01-11 | Medicago Inc | Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina |
US20110091500A1 (en) * | 2008-04-16 | 2011-04-21 | Onderstepoort Biological Products Ltd. | Inactivated Live-Attenuated Bluetongue Virus Vaccine |
TW201010719A (en) * | 2008-08-19 | 2010-03-16 | Wyeth Corp | Immunological composition |
MY159543A (en) * | 2008-11-28 | 2017-01-13 | Merial Inc | Recombinant avian influenza vaccine and uses thereof |
TWI504749B (zh) | 2009-03-16 | 2015-10-21 | Dsm Ip Assets Bv | 於網黏菌門微生物中生產蛋白質之技術 |
-
2011
- 2011-03-11 MA MA35244A patent/MA34087B1/fr unknown
- 2011-03-11 CA CA2792117A patent/CA2792117C/en active Active
- 2011-03-11 US US13/046,317 patent/US9345759B2/en active Active
- 2011-03-11 RU RU2012143624/10A patent/RU2575599C2/ru active
- 2011-03-11 CA CA2792118A patent/CA2792118C/en active Active
- 2011-03-11 US US13/046,255 patent/US20110236416A1/en not_active Abandoned
- 2011-03-11 NZ NZ702145A patent/NZ702145A/en not_active IP Right Cessation
- 2011-03-11 CN CN201180020099.6A patent/CN103687614B/zh active Active
- 2011-03-11 ES ES11709301T patent/ES2795148T3/es active Active
- 2011-03-11 AU AU2011224188A patent/AU2011224188B2/en not_active Ceased
- 2011-03-11 EP EP16171113.0A patent/EP3093025B1/en active Active
- 2011-03-11 EP EP11711411.6A patent/EP2545067B1/en active Active
- 2011-03-11 ES ES11711411.6T patent/ES2617743T3/es active Active
- 2011-03-11 EP EP15167872.9A patent/EP2944322B1/en active Active
- 2011-03-11 WO PCT/US2011/028115 patent/WO2011112945A2/en active Application Filing
- 2011-03-11 BR BR112012023852-3A patent/BR112012023852B1/pt not_active IP Right Cessation
- 2011-03-11 EP EP11709301.3A patent/EP2544716B1/en active Active
- 2011-03-11 NZ NZ602278A patent/NZ602278A/en not_active IP Right Cessation
- 2011-03-11 CN CN201180020079.9A patent/CN103492410A/zh active Pending
- 2011-03-11 BR BR112012023046A patent/BR112012023046B1/pt active IP Right Grant
- 2011-03-11 JP JP2013500104A patent/JP2013522300A/ja active Pending
- 2011-03-11 WO PCT/US2011/028131 patent/WO2011112955A1/en active Application Filing
- 2011-03-14 AR ARP110100797A patent/AR080515A1/es active IP Right Grant
-
2012
- 2012-09-04 IL IL221781A patent/IL221781B/en active IP Right Grant
- 2012-09-04 ZA ZA2012/06619A patent/ZA201206619B/en unknown
-
2016
- 2016-04-14 US US15/098,350 patent/US20170022255A1/en not_active Abandoned
-
2018
- 2018-11-25 IL IL263253A patent/IL263253B/en active IP Right Grant
- 2018-11-25 IL IL263249A patent/IL263249B/en active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012023046A2 (pt) | vacinas de vírus de febre aftosa recombinantes e seus respectivos usos | |
BR112017005833A2 (pt) | vacinas recombinantes fmdv e seus usos | |
BR112018015345A8 (pt) | Vacinas fmdv vetoriadas de adenovírus recombinante e suas utilizações | |
BR112018004242A2 (pt) | composições de vacina que possuem estabilidade e imunogenicidade aumentadas | |
AR069882A1 (es) | Circovirus porcino, molecula de acido nucleico aislada que lo codifica, composicion inmunogenica que lo comprende, vector que comprende por lo menos una molecula de acido nucleico exogena que codifica una proteina de circovirus porcino y metodos para inmunizar un cerdo contra la infeccion virica o e | |
PH12015500092A1 (en) | Compositions for immunising against staphylococcus aureus | |
MX2009006178A (es) | Vacuna contra salmonela. | |
MX347997B (es) | Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle. | |
AR089797A1 (es) | Vacunas contra clostridum difficile que comprenden toxinas recombinantes | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
BR112015008417A8 (pt) | composição imunogênica, vacina, e, uso de uma composição imunogênica | |
AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
BR112018010494A8 (pt) | proteínas de fusão fmdv e e2 e seus usos | |
BR112014001409A2 (pt) | métodos e composições para vacinação contra staphylococcus aureus | |
BR112016007390A2 (pt) | vacina de haemophilus parasuis sorotipo tipo quatro | |
EA201500140A1 (ru) | Ослабленные вакцины от свиного гриппа и способы их получения и применения | |
BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
BR112016012393A8 (pt) | vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado | |
MX2010008170A (es) | Vacunas para influenza canina. | |
UY36328A (es) | Vacunas de fmdv recombinante y usos de las mismas | |
EA201270709A1 (ru) | Композиции вакцины и способы их применения | |
UY33780A (es) | ?composiciones y métodos para vacunar ganado vacuno?. | |
MX2018002112A (es) | Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos. | |
BR102012021810A2 (pt) | Xantana como adjuvante em vacina de subunidade recombinante | |
AR095501A1 (es) | Vacunas rsv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority | ||
B25A | Requested transfer of rights approved |
Owner name: BIOLEX THERAPEUTICS (US) , MERIAL, INC. (US) |
|
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2523 DE 14/05/2019 POR TER SIDO INDEVIDA. |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/03/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25A | Requested transfer of rights approved |
Owner name: BIOLEX THERAPEUTICS (US) ; BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US) |